In Reply to Dalwadi et al
We thank the authors1 for their letter highlighting the critical issues facing the feasibility and efficacy of stereotactic ablative radiation (SAbR) as a boost for patients with cervical cancer unable to receive standard brachytherapy.
Source: International Journal of Radiation Oncology * Biology * Physics - Category: Radiology Authors: Kevin Albuquerque, Robert Timmerman Tags: Comment Source Type: research
More News: Biology | Brachytherapy | Cancer | Cancer & Oncology | Cervical Cancer | Physics | Radiology